|

Omega-3-Acid Ethyl Esters Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Lovaza

Pipeline

Phase 2: 1

Top Sponsors

  • National Cancer Institute (NCI)1

Indications

  • Breast Lobular Carcinoma In Situ1
  • Breast Atypical Hyperplasia1
  • Breast Carcinoma1
  • Breast Ductal Carcinoma In Situ1
  • Breast Cancer1

Kansas City, Kansas1 trial

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

University of Kansas Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.